176 related articles for article (PubMed ID: 37132507)
1. Biomarker-Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union.
Verbaanderd C; Trullás Jimeno A; Engelbergs J; Zander H; Reischl I; Moreno Oliver A; Vamvakas S; Vleminckx C; Bouygues C; Girard T; Day F; Frias Z
Clin Pharmacol Ther; 2023 Aug; 114(2):316-324. PubMed ID: 37132507
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Database Approach to Identify Companion Diagnostic Testing in Clinical Trials under the New In Vitro Diagnostic Medical Devices Regulation.
Wollenhaupt C; Sudhop T; Knoess W
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370933
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency.
Maliepaard M; Nibi P; Nibi G; Pasmooij AMG
Front Med (Lausanne); 2022; 9():893028. PubMed ID: 35602486
[TBL] [Abstract][Full Text] [Related]
4. The new EU regulation on in vitro diagnostics: potential issues at the interface of medicines and companion diagnostics.
Enzmann H; Meyer R; Broich K
Biomark Med; 2016 Dec; 10(12):1261-1268. PubMed ID: 27661101
[TBL] [Abstract][Full Text] [Related]
5. Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines Agency.
Orellana García LP; Ehmann F; Hines PA; Ritzhaupt A; Brand A
Front Med (Lausanne); 2021; 8():753187. PubMed ID: 34790681
[No Abstract] [Full Text] [Related]
6. Impact of the new European Union
Hermans AMM; Maliepaard M; Boon WPC; Pasmooij AMG
Expert Rev Mol Diagn; 2022 May; 22(5):583-590. PubMed ID: 35673983
[TBL] [Abstract][Full Text] [Related]
7. Companion Diagnostics: State of the Art and New Regulations.
Valla V; Alzabin S; Koukoura A; Lewis A; Nielsen AA; Vassiliadis E
Biomark Insights; 2021; 16():11772719211047763. PubMed ID: 34658618
[TBL] [Abstract][Full Text] [Related]
8. ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European
Vanstapel FJLA; Orth M; Streichert T; Capoluongo ED; Oosterhuis WP; Çubukçu HC; Bernabeu-Andreu FA; Thelen M; Jacobs LHJ; Linko S; Bhattoa HP; Bossuyt PMM; Meško Brguljan P; Boursier G; Cobbaert CM; Neumaier M
Clin Chem Lab Med; 2023 Mar; 61(4):608-626. PubMed ID: 36716120
[TBL] [Abstract][Full Text] [Related]
9. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
Tazawa Y
Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
[TBL] [Abstract][Full Text] [Related]
10. Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union.
Pignatti F; Ehmann F; Hemmings R; Jonsson B; Nuebling M; Papaluca-Amati M; Posch M; Rasi G
Clin Cancer Res; 2014 Mar; 20(6):1458-68. PubMed ID: 24634469
[TBL] [Abstract][Full Text] [Related]
11. Structure and content of the EU-IVDR : Current status and implications for pathology.
Kahles A; Goldschmid H; Volckmar AL; Ploeger C; Kazdal D; Penzel R; Budczies J; Kempny G; Kazmierczak M; Flechtenmacher C; Baretton G; Weichert W; Horst D; Klauschen F; Gassner UM; Brüggemann M; Vogeser M; Schirmacher P; Stenzinger A
Pathologie (Heidelb); 2023 Nov; 44(Suppl 2):73-85. PubMed ID: 36735063
[TBL] [Abstract][Full Text] [Related]
12. CDx, NGS and regulation: five perspectives from the Pistoia Alliance.
Wise J; Furness M; McWilliams S; Patton S
Drug Discov Today; 2019 Nov; 24(11):2120-2125. PubMed ID: 31306783
[TBL] [Abstract][Full Text] [Related]
13. [Structure and content of the EU-IVDR : Current status and implications for pathology].
Kahles A; Goldschmid H; Volckmar AL; Plöger C; Kazdal D; Penzel R; Budczies J; Kempny G; Kazmierczak M; Flechtenmacher C; Baretton G; Weichert W; Horst D; Klauschen F; Gassner UM; Brüggemann M; Vogeser M; Schirmacher P; Stenzinger A
Pathologie (Heidelb); 2022 Sep; 43(5):351-364. PubMed ID: 35925306
[TBL] [Abstract][Full Text] [Related]
14. 2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (
Kholmanskikh O; Wang YM; Hersey S; Wadhwa M; Block K; Bandukwala A; Szapacs M; Weiner R; Awwad K; Dessy F; Downing S; Du X; Garofolo F; Harris S; Hou V; Jones J; Kar S; Kinhikar A; Li M; Mathews J; Meissen J; Sumner GO; Pan L; Sanderink G; Scully I; Stanta J; Tanaka Y; Vauleon S; Wagner L; Wang K; Zhu L; Eck S; Lin YD; Azadeh M; Decman V; Diebold S; Du X; Goihberg P; Alcaide EG; Gonneau C; Hedrick MN; Hopkins G; Kar S; Loschko J; McCausland M; Mendez L; Sehra S; Stevens E; Sun YS; Tangri S; Trampont PC; Cludts I; Dysinger M; Kavita U; Sugimoto H; Chilewski S; Grimaldi C; Jiang Y; Kamerud J; Liu S; Owen C; Palackal N; Petit-Frere C; Pine S; Abhari MR; Scheibner K; Williams L; Xu T; Zhang G
Bioanalysis; 2024; 16(8):179-220. PubMed ID: 38899739
[TBL] [Abstract][Full Text] [Related]
15. Implementing Regulation (EU) 2017/746 of 5 April 2017 on In vitro Diagnostic Medical Devices (IVDR) in Medical Laboratories, especially in Ophthalmopathology.
Auw-Hädrich C; Reinhard T; Hädrich J
Klin Monbl Augenheilkd; 2022 Jul; 239(7):905-912. PubMed ID: 35636459
[TBL] [Abstract][Full Text] [Related]
16. Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries.
Govaerts L; Simoens S; Van Dyck W; Huys I
Value Health; 2020 May; 23(5):606-615. PubMed ID: 32389226
[TBL] [Abstract][Full Text] [Related]
17. Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing.
Testa S; Meijer P; Lasne D; Mullier F
Int J Lab Hematol; 2022 Sep; 44 Suppl 1():71-78. PubMed ID: 36074714
[TBL] [Abstract][Full Text] [Related]
18. Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR).
Hoffmüller P; Brüggemann M; Eggermann T; Ghoreschi K; Haase D; Hofmann J; Hunfeld KP; Koch K; Meisel C; Michl P; Müller J; Müller C; Rabenau HF; Reinhardt D; Riemenschneider MJ; Sachs UJ; Sack U; Stenzinger A; Streichert T; von Neuhoff N; Weichert W; Weinstock C; Zimmermann S; Spitzenberger F;
Ger Med Sci; 2021; 19():Doc08. PubMed ID: 34194291
[TBL] [Abstract][Full Text] [Related]
19. Necessity of strengthening the current clinical regulatory for companion diagnostics: An institutional comparison of the FDA, EMA, and MFDS.
Kang SL; Woo JH; Kim NH; Kwon JY; Kim SM
Mol Ther Methods Clin Dev; 2023 Sep; 30():447-458. PubMed ID: 37663648
[TBL] [Abstract][Full Text] [Related]
20. Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology.
Kahles A; Goldschmid H; Volckmar AL; Ploeger C; Kazdal D; Penzel R; Budczies J; Flechtenmacher C; Gassner UM; Brüggemann M; Vogeser M; Schirmacher P; Stenzinger A
Pathologie (Heidelb); 2023 Nov; 44(Suppl 2):86-95. PubMed ID: 38047950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
